Pinion John Richard 4
4 · Ultragenyx Pharmaceutical Inc. · Filed May 19, 2023
Insider Transaction Report
Form 4
Pinion John Richard
See Remarks
Transactions
- Sale
Common Stock
2023-05-18$50.00/sh−2,012$100,600→ 74,744 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person prior to February 27, 2023.
- [F2]Includes 596 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2023.
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.